BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17557143)

  • 1. Trafficking of FoxP3+ regulatory T cells: myths and facts.
    Kim CH
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):151-9. PubMed ID: 17557143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXP3 modifies the phenotypic and functional properties of regulatory T cells.
    Campbell DJ; Ziegler SF
    Nat Rev Immunol; 2007 Apr; 7(4):305-10. PubMed ID: 17380159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?
    Curotto de Lafaille MA; Lafaille JJ
    Immunity; 2009 May; 30(5):626-35. PubMed ID: 19464985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding and converting regulatory T cells: a horizon for immunotherapy.
    Khattar M; Chen W; Stepkowski SM
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected patients.
    Miyaaki H; Zhou H; Ichikawa T; Nakao K; Shibata H; Takeshita S; Akiyama M; Ozawa E; Miuma S; Eguchi K
    Liver Int; 2009 May; 29(5):702-7. PubMed ID: 18673437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural aspects of the FOXP3 regulatory complex as an immunopharmacological target.
    Zhou Z; Song X; Berezov A; Li B; Greene MI
    Int Immunopharmacol; 2009 May; 9(5):518-20. PubMed ID: 19539569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta-producing Foxp3(+)CD8(+)CD25(+) T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions.
    Sugita S; Futagami Y; Horie S; Mochizuki M
    Exp Eye Res; 2007 Nov; 85(5):626-36. PubMed ID: 17720157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent thymic origin, differentiation, and turnover of regulatory T cells.
    Mabarrack NH; Turner NL; Mayrhofer G
    J Leukoc Biol; 2008 Nov; 84(5):1287-97. PubMed ID: 18682578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.
    Zheng Y; Josefowicz SZ; Kas A; Chu TT; Gavin MA; Rudensky AY
    Nature; 2007 Feb; 445(7130):936-40. PubMed ID: 17237761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.
    Huang LF; Yao YM; Zhang LT; Dong N; Yu Y; Sheng ZY
    Shock; 2009 Mar; 31(3):322-9. PubMed ID: 18665051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease.
    Saruta M; Yu QT; Fleshner PR; Mantel PY; Schmidt-Weber CB; Banham AH; Papadakis KA
    Clin Immunol; 2007 Dec; 125(3):281-90. PubMed ID: 17897887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
    Ndhlovu LC; Loo CP; Spotts G; Nixon DF; Hecht FM
    J Leukoc Biol; 2008 Feb; 83(2):254-62. PubMed ID: 17982112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxp3 is required throughout the life of a regulatory T cell.
    Lopes JE; Soper DM; Ziegler SF
    Sci STKE; 2007 Jul; 2007(393):pe36. PubMed ID: 17609478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
    Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT
    Nat Immunol; 2007 Sep; 8(9):931-41. PubMed ID: 17694059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintaining immunological tolerance with Foxp3.
    Mays LE; Chen YH
    Cell Res; 2007 Nov; 17(11):904-18. PubMed ID: 17923863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Foxp3 protein expression in porcine T lymphocytes.
    Käser T; Gerner W; Hammer SE; Patzl M; Saalmüller A
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):92-101. PubMed ID: 18565594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.